Lymphoma therapy: the challenges ahead.
Ian W
IW
Flinn
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017209:Apoptosis; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D011379:Prognosis; D018124:Receptors, Tumor Necrosis Factor / Q000187:drug effects
D000911:Antibodies, Monoclonal; D018124:Receptors, Tumor Necrosis Factor